Agios Pharmaceuticals (AGIO) Competitors $30.84 +0.44 (+1.45%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$31.06 +0.22 (+0.70%) As of 03/27/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGIO vs. RVMD, BBIO, LNTH, TGTX, LEGN, AXSM, TLX, BPMC, KRYS, and NUVLShould you be buying Agios Pharmaceuticals stock or one of its competitors? The main competitors of Agios Pharmaceuticals include Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Lantheus (LNTH), TG Therapeutics (TGTX), Legend Biotech (LEGN), Axsome Therapeutics (AXSM), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Krystal Biotech (KRYS), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Agios Pharmaceuticals vs. Revolution Medicines BridgeBio Pharma Lantheus TG Therapeutics Legend Biotech Axsome Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Krystal Biotech Nuvalent Agios Pharmaceuticals (NASDAQ:AGIO) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability. Do insiders and institutionals have more ownership in AGIO or RVMD? 94.3% of Revolution Medicines shares are owned by institutional investors. 4.9% of Agios Pharmaceuticals shares are owned by insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer AGIO or RVMD? Agios Pharmaceuticals received 396 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 76.61% of users gave Revolution Medicines an outperform vote while only 66.98% of users gave Agios Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAgios PharmaceuticalsOutperform Votes49166.98% Underperform Votes24233.02% Revolution MedicinesOutperform Votes9576.61% Underperform Votes2923.39% Which has more volatility & risk, AGIO or RVMD? Agios Pharmaceuticals has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Is AGIO or RVMD more profitable? Agios Pharmaceuticals has a net margin of 1,845.92% compared to Revolution Medicines' net margin of 0.00%. Agios Pharmaceuticals' return on equity of -2.51% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Agios Pharmaceuticals1,845.92% -2.51% -2.26% Revolution Medicines N/A -33.67%-30.08% Does the media favor AGIO or RVMD? In the previous week, Agios Pharmaceuticals had 4 more articles in the media than Revolution Medicines. MarketBeat recorded 9 mentions for Agios Pharmaceuticals and 5 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.43 beat Agios Pharmaceuticals' score of 1.04 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agios Pharmaceuticals 3 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, AGIO or RVMD? Agios Pharmaceuticals has higher revenue and earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgios Pharmaceuticals$36.50M48.41$673.72M$11.342.72Revolution Medicines$742K9,546.21-$436.37M-$3.57-10.67 Do analysts prefer AGIO or RVMD? Agios Pharmaceuticals currently has a consensus price target of $56.57, indicating a potential upside of 83.44%. Revolution Medicines has a consensus price target of $66.31, indicating a potential upside of 74.04%. Given Agios Pharmaceuticals' higher possible upside, equities research analysts plainly believe Agios Pharmaceuticals is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agios Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 3.08 SummaryAgios Pharmaceuticals beats Revolution Medicines on 10 of the 19 factors compared between the two stocks. Remove Ads Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGIO vs. The Competition Export to ExcelMetricAgios PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.74B$6.91B$5.64B$8.06BDividend YieldN/A2.73%4.57%4.02%P/E Ratio2.727.2023.1319.03Price / Sales48.41226.01383.8993.17Price / CashN/A65.6738.1634.64Price / Book1.146.476.944.33Net Income$673.72M$141.90M$3.20B$247.06M7 Day Performance-5.72%-3.05%-2.30%-0.52%1 Month Performance-10.26%-4.63%3.10%-3.73%1 Year Performance5.91%-8.61%11.22%1.74% Agios Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGIOAgios Pharmaceuticals4.3645 of 5 stars$30.84+1.4%$56.57+83.4%+5.9%$1.74B$36.50M2.72390Short Interest ↓Positive NewsRVMDRevolution Medicines4.1616 of 5 stars$39.34+3.2%$66.31+68.6%+20.1%$7.31B$742,000.00-10.96250Positive NewsBBIOBridgeBio Pharma4.6261 of 5 stars$37.22+7.0%$52.90+42.1%+18.0%$7.08B$221.90M-13.06400Insider TradeHigh Trading VolumeLNTHLantheus4.2972 of 5 stars$99.44+1.8%$129.43+30.2%+60.5%$6.81B$1.53B16.55700TGTXTG Therapeutics3.0867 of 5 stars$42.61-0.9%$40.67-4.6%+158.2%$6.69B$329.00M-426.06290Positive NewsLEGNLegend Biotech2.8876 of 5 stars$36.33-1.7%$79.00+117.5%-37.8%$6.67B$627.24M-38.241,800Short Interest ↓Positive NewsAXSMAxsome Therapeutics4.7721 of 5 stars$129.17+1.9%$167.36+29.6%+53.8%$6.30B$385.69M-21.56380Analyst ForecastShort Interest ↓TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$18.24+2.5%$22.00+20.6%N/A$6.14B$783.21M0.00N/AGap UpBPMCBlueprint Medicines2.7866 of 5 stars$95.27+7.4%$124.95+31.2%-5.3%$6.09B$508.82M-88.21640Insider TradePositive NewsKRYSKrystal Biotech4.7179 of 5 stars$194.44+3.9%$220.00+13.1%+3.1%$5.60B$290.52M65.03210Positive NewsNUVLNuvalent2.4526 of 5 stars$77.14-1.1%$113.10+46.6%-3.9%$5.52BN/A-22.2340Positive News Remove Ads Related Companies and Tools Related Companies Revolution Medicines Alternatives BridgeBio Pharma Alternatives Lantheus Alternatives TG Therapeutics Alternatives Legend Biotech Alternatives Axsome Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Blueprint Medicines Alternatives Krystal Biotech Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AGIO) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGIO Stock Free AGIO Stock Alerts